11 – 20 of 78
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Tumour suppressor 15-hydroxyprostaglandin dehydrogenase induces differentiation in colon cancer via GLI1 inhibition
(
- Contribution to journal › Article
-
Mark
Tumour-suppressive effect of oestrogen receptor β in colorectal cancer patients, colon cancer cells, and a zebrafish model
(
- Contribution to journal › Article
- 2019
-
Mark
The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer
(
- Contribution to journal › Article
-
Mark
High expression of estrogen receptor beta correlates with anti-tumorigenic and anti-proliferative inflammatory proteins in colorectal cancer patients
(
- Contribution to journal › Article
-
Mark
To investigate the role of PGD2 and its receptor signalling in colon cancer pathophysiology
(
- Contribution to journal › Article
-
Mark
15-PGDH regulated PD-1/PD-L1 immune checkpoint blockade immunotherapy in colon cancer is a TNF-α dependent phenomenon
(
- Contribution to journal › Article
- 2018
-
Mark
Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer
(
- Contribution to journal › Article
-
Mark
Anti-angiogenic action of leukotriene-C4 induced 15-hydroxyprostaglandin dehydrogenase in colon cancer cells is a TNF-α dependent phenomenon
(
- Contribution to journal › Article
- 2017
-
Mark
Association of the oestrogen receptor beta with hormone status and prognosis in a cohort of female patients with colorectal cancer
(
- Contribution to journal › Article
-
Mark
Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer
(
- Contribution to journal › Article